Building on our solid operations in Europe, we are committed to creating a strong and sustainable clinical research infrastructure and bringing world-class health research skills and clinical trial execution to Africa
Our Brand Promise
We help advance health
through data excellence
- We specialise in public health, clinical and epidemiological research.
- We have a strong track record of collaborating with both private and public partners globally.
- We contribute to the collection, management and reporting of robust and reliable data that impact people’s lives around the world.
See below to learn more about our new identity.
Our identity
Our Solutions

Interventional Studies
Planning and execution of your early stage trials to ensure timely completion of your clinical development programmes.

Capacity Building

Observational Studies

Implementation Research
Recent Blog Posts
Pharmalys Founder and CEO Marieme Ba at PCMG25: The Future of Clinical Trials in Africa
In June 2025, Marieme Ba, Founder and CEO of Pharmalys, took the stage at the PCMG25 Annual Assembly in Málaga, joining fellow panellists Pierre Brichot (MCT-CRO), Jacqueline Mirera (CREA-N), and Chris Obwanga (IQVIA), in a session chaired by Sandra Johnson. Their...
A Breakthrough in Malaria Care for the Youngest Patients
It’s a sobering truth: malaria still claims the lives of hundreds of thousands of children every year, with the youngest being most at risk. Until now, doctors treating newborns and very small infants under 5 kg faced a dilemma - no treatment had ever been designed...
Pharmacoequity: Improving Representation in Medicine and Fairness in Care
Access to safe and effective medicines is a cornerstone of modern healthcare. Yet, not everyone enjoys equal benefit from the advancements in pharmaceutical research and innovation. Pharmacoequity is the principle that every individual, regardless of race, ethnicity,...